nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—STK10—renal vein—abdominal aortic aneurysm	0.0844	0.191	CbGeAlD
Vandetanib—STK10—renal artery—abdominal aortic aneurysm	0.0567	0.129	CbGeAlD
Vandetanib—KDR—hindlimb—abdominal aortic aneurysm	0.0161	0.0366	CbGeAlD
Vandetanib—LYN—blood plasma—abdominal aortic aneurysm	0.0145	0.0329	CbGeAlD
Vandetanib—FLT3—blood plasma—abdominal aortic aneurysm	0.0124	0.0282	CbGeAlD
Vandetanib—TEK—artery—abdominal aortic aneurysm	0.0121	0.0274	CbGeAlD
Vandetanib—SRC—artery—abdominal aortic aneurysm	0.0107	0.0244	CbGeAlD
Vandetanib—KDR—artery—abdominal aortic aneurysm	0.00989	0.0224	CbGeAlD
Vandetanib—FYN—blood plasma—abdominal aortic aneurysm	0.00929	0.021	CbGeAlD
Vandetanib—STK10—blood plasma—abdominal aortic aneurysm	0.0083	0.0188	CbGeAlD
Vandetanib—SRC—blood plasma—abdominal aortic aneurysm	0.00806	0.0183	CbGeAlD
Vandetanib—TYRO3—connective tissue—abdominal aortic aneurysm	0.00778	0.0176	CbGeAlD
Vandetanib—LYN—connective tissue—abdominal aortic aneurysm	0.00774	0.0175	CbGeAlD
Vandetanib—KDR—blood plasma—abdominal aortic aneurysm	0.00742	0.0168	CbGeAlD
Vandetanib—FLT3—connective tissue—abdominal aortic aneurysm	0.00661	0.015	CbGeAlD
Vandetanib—RIPK2—connective tissue—abdominal aortic aneurysm	0.00597	0.0135	CbGeAlD
Vandetanib—ERBB3—connective tissue—abdominal aortic aneurysm	0.00572	0.013	CbGeAlD
Vandetanib—RET—connective tissue—abdominal aortic aneurysm	0.0053	0.012	CbGeAlD
Vandetanib—AXL—connective tissue—abdominal aortic aneurysm	0.00528	0.012	CbGeAlD
Vandetanib—TYRO3—spinal cord—abdominal aortic aneurysm	0.00516	0.0117	CbGeAlD
Vandetanib—EPHA5—spinal cord—abdominal aortic aneurysm	0.00516	0.0117	CbGeAlD
Vandetanib—FMO1—kidney—abdominal aortic aneurysm	0.00505	0.0114	CbGeAlD
Vandetanib—FYN—connective tissue—abdominal aortic aneurysm	0.00494	0.0112	CbGeAlD
Vandetanib—ERBB3—kidney—abdominal aortic aneurysm	0.00487	0.011	CbGeAlD
Vandetanib—TEK—connective tissue—abdominal aortic aneurysm	0.00483	0.011	CbGeAlD
Vandetanib—RET—kidney—abdominal aortic aneurysm	0.00451	0.0102	CbGeAlD
Vandetanib—YES1—connective tissue—abdominal aortic aneurysm	0.00446	0.0101	CbGeAlD
Vandetanib—SRC—connective tissue—abdominal aortic aneurysm	0.00429	0.00973	CbGeAlD
Vandetanib—FYN—kidney—abdominal aortic aneurysm	0.00421	0.00954	CbGeAlD
Vandetanib—TEK—kidney—abdominal aortic aneurysm	0.00411	0.00932	CbGeAlD
Vandetanib—RIPK2—spinal cord—abdominal aortic aneurysm	0.00396	0.00898	CbGeAlD
Vandetanib—VEGFA—spinal cord—abdominal aortic aneurysm	0.00395	0.00895	CbGeAlD
Vandetanib—KDR—connective tissue—abdominal aortic aneurysm	0.00395	0.00895	CbGeAlD
Vandetanib—IRAK4—spinal cord—abdominal aortic aneurysm	0.00387	0.00877	CbGeAlD
Vandetanib—YES1—kidney—abdominal aortic aneurysm	0.0038	0.00861	CbGeAlD
Vandetanib—ERBB3—spinal cord—abdominal aortic aneurysm	0.00379	0.00859	CbGeAlD
Vandetanib—STK10—kidney—abdominal aortic aneurysm	0.00376	0.00853	CbGeAlD
Vandetanib—SRC—kidney—abdominal aortic aneurysm	0.00365	0.00828	CbGeAlD
Vandetanib—MKNK1—spinal cord—abdominal aortic aneurysm	0.00356	0.00807	CbGeAlD
Vandetanib—RET—spinal cord—abdominal aortic aneurysm	0.00352	0.00797	CbGeAlD
Vandetanib—AXL—spinal cord—abdominal aortic aneurysm	0.0035	0.00794	CbGeAlD
Vandetanib—PDGFRB—connective tissue—abdominal aortic aneurysm	0.00342	0.00775	CbGeAlD
Vandetanib—SLK—spinal cord—abdominal aortic aneurysm	0.00337	0.00764	CbGeAlD
Vandetanib—KDR—kidney—abdominal aortic aneurysm	0.00336	0.00762	CbGeAlD
Vandetanib—FYN—spinal cord—abdominal aortic aneurysm	0.00328	0.00743	CbGeAlD
Vandetanib—TEK—spinal cord—abdominal aortic aneurysm	0.0032	0.00726	CbGeAlD
Vandetanib—MAP4K5—spinal cord—abdominal aortic aneurysm	0.0032	0.00726	CbGeAlD
Vandetanib—EPHB6—spinal cord—abdominal aortic aneurysm	0.00306	0.00694	CbGeAlD
Vandetanib—ABL1—connective tissue—abdominal aortic aneurysm	0.00305	0.00691	CbGeAlD
Vandetanib—YES1—spinal cord—abdominal aortic aneurysm	0.00296	0.00671	CbGeAlD
Vandetanib—PDGFRB—kidney—abdominal aortic aneurysm	0.00291	0.0066	CbGeAlD
Vandetanib—SRC—spinal cord—abdominal aortic aneurysm	0.00285	0.00645	CbGeAlD
Vandetanib—MAP2K5—spinal cord—abdominal aortic aneurysm	0.00262	0.00593	CbGeAlD
Vandetanib—KDR—spinal cord—abdominal aortic aneurysm	0.00262	0.00593	CbGeAlD
Vandetanib—ABL1—kidney—abdominal aortic aneurysm	0.00259	0.00588	CbGeAlD
Vandetanib—CYP3A4—blood plasma—abdominal aortic aneurysm	0.00251	0.0057	CbGeAlD
Vandetanib—PDGFRB—spinal cord—abdominal aortic aneurysm	0.00227	0.00514	CbGeAlD
Vandetanib—ORM1—spinal cord—abdominal aortic aneurysm	0.00213	0.00482	CbGeAlD
Vandetanib—ABL1—spinal cord—abdominal aortic aneurysm	0.00202	0.00458	CbGeAlD
Vandetanib—ABCG2—spinal cord—abdominal aortic aneurysm	0.00127	0.00289	CbGeAlD
Vandetanib—CYP3A4—kidney—abdominal aortic aneurysm	0.00114	0.00258	CbGeAlD
Vandetanib—FYN—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000153	0.000275	CbGpPWpGaD
Vandetanib—EGFR—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000153	0.000273	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000152	0.000272	CbGpPWpGaD
Vandetanib—EGFR—Disease—LDLR—abdominal aortic aneurysm	0.000152	0.000272	CbGpPWpGaD
Vandetanib—ABCC1—Disease—NCF1—abdominal aortic aneurysm	0.000151	0.00027	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—APOE—abdominal aortic aneurysm	0.000151	0.00027	CbGpPWpGaD
Vandetanib—ERBB3—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.00015	0.000269	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.00015	0.000268	CbGpPWpGaD
Vandetanib—LCK—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.00015	0.000268	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000149	0.000267	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000149	0.000267	CbGpPWpGaD
Vandetanib—SRC—Disease—AAAS—abdominal aortic aneurysm	0.000149	0.000266	CbGpPWpGaD
Vandetanib—LCK—Immune System—NCF1—abdominal aortic aneurysm	0.000148	0.000266	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000148	0.000264	CbGpPWpGaD
Vandetanib—LCK—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000147	0.000263	CbGpPWpGaD
Vandetanib—LCK—Disease—LDLR—abdominal aortic aneurysm	0.000146	0.000262	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—NOS2—abdominal aortic aneurysm	0.000146	0.000261	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000145	0.00026	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000145	0.00026	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000145	0.000259	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—PTGS2—abdominal aortic aneurysm	0.000144	0.000258	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000144	0.000257	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000143	0.000257	CbGpPWpGaD
Vandetanib—ALB—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.000143	0.000255	CbGpPWpGaD
Vandetanib—EGFR—Disease—NCF1—abdominal aortic aneurysm	0.000142	0.000254	CbGpPWpGaD
Vandetanib—ERBB3—Disease—APOE—abdominal aortic aneurysm	0.000141	0.000253	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.00014	0.000251	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00014	0.000251	CbGpPWpGaD
Vandetanib—EGFR—Axon guidance—MMP9—abdominal aortic aneurysm	0.00014	0.00025	CbGpPWpGaD
Vandetanib—YES1—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000137	0.000246	CbGpPWpGaD
Vandetanib—LCK—Disease—NCF1—abdominal aortic aneurysm	0.000137	0.000245	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—AAAS—abdominal aortic aneurysm	0.000136	0.000244	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000135	0.000242	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000135	0.000242	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—LDLR—abdominal aortic aneurysm	0.000135	0.000242	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000133	0.000238	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000133	0.000237	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000133	0.000237	CbGpPWpGaD
Vandetanib—YES1—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000132	0.000236	CbGpPWpGaD
Vandetanib—ERBB3—Disease—NOS2—abdominal aortic aneurysm	0.000132	0.000236	CbGpPWpGaD
Vandetanib—SRC—Immune System—NCF1—abdominal aortic aneurysm	0.000131	0.000235	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000131	0.000235	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000131	0.000235	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000131	0.000235	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00013	0.000234	CbGpPWpGaD
Vandetanib—SRC—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.00013	0.000233	CbGpPWpGaD
Vandetanib—SRC—Disease—LDLR—abdominal aortic aneurysm	0.00013	0.000232	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000129	0.000232	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—NOS2—abdominal aortic aneurysm	0.000129	0.000231	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000128	0.000229	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000128	0.000229	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000127	0.000227	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000126	0.000226	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000125	0.000224	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000123	0.00022	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000123	0.00022	CbGpPWpGaD
Vandetanib—SRC—Disease—NCF1—abdominal aortic aneurysm	0.000121	0.000217	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000121	0.000217	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000121	0.000216	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.00012	0.000215	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00012	0.000214	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00012	0.000214	CbGpPWpGaD
Vandetanib—SRC—Axon guidance—MMP9—abdominal aortic aneurysm	0.000119	0.000213	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—LDLR—abdominal aortic aneurysm	0.000119	0.000213	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000117	0.00021	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000117	0.000209	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000117	0.000209	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000116	0.000208	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000116	0.000207	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000115	0.000206	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000115	0.000206	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000115	0.000206	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000115	0.000205	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—NFKB1—abdominal aortic aneurysm	0.000114	0.000204	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000114	0.000204	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000113	0.000202	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000112	0.000201	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000112	0.000201	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000112	0.000201	CbGpPWpGaD
Vandetanib—ERBB3—Disease—SERPINE1—abdominal aortic aneurysm	0.000111	0.000199	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000109	0.000195	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000108	0.000193	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000106	0.00019	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000105	0.000188	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000105	0.000187	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—NFKB1—abdominal aortic aneurysm	0.000103	0.000185	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—PTGS2—abdominal aortic aneurysm	0.000103	0.000185	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000103	0.000184	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000103	0.000184	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000102	0.000183	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000102	0.000183	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000102	0.000182	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000101	0.000181	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000101	0.00018	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.0001	0.00018	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.0001	0.00018	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—APOE—abdominal aortic aneurysm	0.0001	0.000179	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—MMP9—abdominal aortic aneurysm	9.96e-05	0.000178	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NCF1—abdominal aortic aneurysm	9.96e-05	0.000178	CbGpPWpGaD
Vandetanib—BLK—Immune System—NFKB1—abdominal aortic aneurysm	9.94e-05	0.000178	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	9.94e-05	0.000178	CbGpPWpGaD
Vandetanib—FGR—Immune System—NFKB1—abdominal aortic aneurysm	9.9e-05	0.000177	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—APOE—abdominal aortic aneurysm	9.9e-05	0.000177	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—NFKB1—abdominal aortic aneurysm	9.86e-05	0.000176	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	9.83e-05	0.000176	CbGpPWpGaD
Vandetanib—ERBB3—Disease—PTGS2—abdominal aortic aneurysm	9.69e-05	0.000173	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	9.68e-05	0.000173	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—AGTR1—abdominal aortic aneurysm	9.6e-05	0.000172	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NCF1—abdominal aortic aneurysm	9.59e-05	0.000172	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—AGT—abdominal aortic aneurysm	9.52e-05	0.00017	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—APOE—abdominal aortic aneurysm	9.45e-05	0.000169	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—CCL2—abdominal aortic aneurysm	9.44e-05	0.000169	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—AGTR1—abdominal aortic aneurysm	9.4e-05	0.000168	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—AGTR1—abdominal aortic aneurysm	9.25e-05	0.000166	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—AGT—abdominal aortic aneurysm	9.18e-05	0.000164	CbGpPWpGaD
Vandetanib—FYN—Disease—APOE—abdominal aortic aneurysm	9.11e-05	0.000163	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—NFKB1—abdominal aortic aneurysm	9.11e-05	0.000163	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—LDLR—abdominal aortic aneurysm	9.08e-05	0.000162	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—APOE—abdominal aortic aneurysm	9e-05	0.000161	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—AGT—abdominal aortic aneurysm	8.87e-05	0.000159	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	8.81e-05	0.000158	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—NOS2—abdominal aortic aneurysm	8.81e-05	0.000158	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—NOS2—abdominal aortic aneurysm	8.73e-05	0.000156	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—NFKB1—abdominal aortic aneurysm	8.7e-05	0.000156	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	8.7e-05	0.000156	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—APOE—abdominal aortic aneurysm	8.69e-05	0.000156	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—CCL2—abdominal aortic aneurysm	8.63e-05	0.000154	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MMP3—abdominal aortic aneurysm	8.56e-05	0.000153	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	8.53e-05	0.000153	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—MMP9—abdominal aortic aneurysm	8.5e-05	0.000152	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NCF1—abdominal aortic aneurysm	8.49e-05	0.000152	CbGpPWpGaD
Vandetanib—FYN—Disease—NOS2—abdominal aortic aneurysm	8.49e-05	0.000152	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—CCL2—abdominal aortic aneurysm	8.41e-05	0.000151	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—NFKB1—abdominal aortic aneurysm	8.41e-05	0.00015	CbGpPWpGaD
Vandetanib—ALB—Metabolism—AAAS—abdominal aortic aneurysm	8.4e-05	0.00015	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—NFKB1—abdominal aortic aneurysm	8.39e-05	0.00015	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MMP3—abdominal aortic aneurysm	8.38e-05	0.00015	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	8.36e-05	0.00015	CbGpPWpGaD
Vandetanib—ABCC1—Disease—APOE—abdominal aortic aneurysm	8.35e-05	0.000149	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—CCL2—abdominal aortic aneurysm	8.32e-05	0.000149	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MMP3—abdominal aortic aneurysm	8.25e-05	0.000148	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	8.06e-05	0.000144	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	8.06e-05	0.000144	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—AGTR1—abdominal aortic aneurysm	7.99e-05	0.000143	CbGpPWpGaD
Vandetanib—YES1—Immune System—NFKB1—abdominal aortic aneurysm	7.99e-05	0.000143	CbGpPWpGaD
Vandetanib—EGFR—Disease—APOE—abdominal aortic aneurysm	7.87e-05	0.000141	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	7.86e-05	0.000141	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—CCL2—abdominal aortic aneurysm	7.84e-05	0.00014	CbGpPWpGaD
Vandetanib—ABCC1—Disease—NOS2—abdominal aortic aneurysm	7.78e-05	0.000139	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	7.77e-05	0.000139	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—AGTR1—abdominal aortic aneurysm	7.7e-05	0.000138	CbGpPWpGaD
Vandetanib—LCK—Disease—APOE—abdominal aortic aneurysm	7.59e-05	0.000136	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—CCL2—abdominal aortic aneurysm	7.56e-05	0.000135	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—NFKB1—abdominal aortic aneurysm	7.43e-05	0.000133	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—SERPINE1—abdominal aortic aneurysm	7.42e-05	0.000133	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—SERPINE1—abdominal aortic aneurysm	7.35e-05	0.000132	CbGpPWpGaD
Vandetanib—EGFR—Disease—NOS2—abdominal aortic aneurysm	7.33e-05	0.000131	CbGpPWpGaD
Vandetanib—ALB—Metabolism—LDLR—abdominal aortic aneurysm	7.33e-05	0.000131	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—CCL2—abdominal aortic aneurysm	7.31e-05	0.000131	CbGpPWpGaD
Vandetanib—FYN—Disease—SERPINE1—abdominal aortic aneurysm	7.15e-05	0.000128	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—AGT—abdominal aortic aneurysm	7.14e-05	0.000128	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	7.13e-05	0.000128	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MMP3—abdominal aortic aneurysm	7.13e-05	0.000127	CbGpPWpGaD
Vandetanib—LCK—Disease—NOS2—abdominal aortic aneurysm	7.07e-05	0.000126	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	7.06e-05	0.000126	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—APOE—abdominal aortic aneurysm	6.99e-05	0.000125	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MMP3—abdominal aortic aneurysm	6.87e-05	0.000123	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—AGTR1—abdominal aortic aneurysm	6.82e-05	0.000122	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	6.82e-05	0.000122	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—AGT—abdominal aortic aneurysm	6.76e-05	0.000121	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—MMP9—abdominal aortic aneurysm	6.75e-05	0.000121	CbGpPWpGaD
Vandetanib—SRC—Disease—APOE—abdominal aortic aneurysm	6.72e-05	0.00012	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	6.68e-05	0.00012	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—APOE—abdominal aortic aneurysm	6.62e-05	0.000118	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—AGT—abdominal aortic aneurysm	6.61e-05	0.000118	CbGpPWpGaD
Vandetanib—ABCC1—Disease—SERPINE1—abdominal aortic aneurysm	6.55e-05	0.000117	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—AGT—abdominal aortic aneurysm	6.51e-05	0.000117	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—APOE—abdominal aortic aneurysm	6.48e-05	0.000116	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—PTGS2—abdominal aortic aneurysm	6.48e-05	0.000116	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—APOE—abdominal aortic aneurysm	6.38e-05	0.000114	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—AGT—abdominal aortic aneurysm	6.28e-05	0.000112	CbGpPWpGaD
Vandetanib—SRC—Disease—NOS2—abdominal aortic aneurysm	6.26e-05	0.000112	CbGpPWpGaD
Vandetanib—FYN—Disease—PTGS2—abdominal aortic aneurysm	6.24e-05	0.000112	CbGpPWpGaD
Vandetanib—EGFR—Disease—SERPINE1—abdominal aortic aneurysm	6.18e-05	0.000111	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—MMP9—abdominal aortic aneurysm	6.17e-05	0.00011	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—APOE—abdominal aortic aneurysm	6.15e-05	0.00011	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—NFKB1—abdominal aortic aneurysm	6.11e-05	0.000109	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—NFKB1—abdominal aortic aneurysm	6.09e-05	0.000109	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MMP3—abdominal aortic aneurysm	6.08e-05	0.000109	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—MMP9—abdominal aortic aneurysm	6.02e-05	0.000108	CbGpPWpGaD
Vandetanib—LYN—Immune System—NFKB1—abdominal aortic aneurysm	5.96e-05	0.000107	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—NFKB1—abdominal aortic aneurysm	5.95e-05	0.000107	CbGpPWpGaD
Vandetanib—LCK—Disease—SERPINE1—abdominal aortic aneurysm	5.95e-05	0.000107	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—MMP9—abdominal aortic aneurysm	5.95e-05	0.000106	CbGpPWpGaD
Vandetanib—ABL1—Immune System—NFKB1—abdominal aortic aneurysm	5.93e-05	0.000106	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—NFKB1—abdominal aortic aneurysm	5.89e-05	0.000105	CbGpPWpGaD
Vandetanib—FYN—Immune System—NFKB1—abdominal aortic aneurysm	5.87e-05	0.000105	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	5.84e-05	0.000105	CbGpPWpGaD
Vandetanib—ABCC1—Disease—PTGS2—abdominal aortic aneurysm	5.72e-05	0.000102	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—AGT—abdominal aortic aneurysm	5.63e-05	0.000101	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CCL2—abdominal aortic aneurysm	5.56e-05	9.96e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—APOE—abdominal aortic aneurysm	5.51e-05	9.86e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CCL2—abdominal aortic aneurysm	5.45e-05	9.75e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—AGT—abdominal aortic aneurysm	5.42e-05	9.7e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MMP9—abdominal aortic aneurysm	5.41e-05	9.68e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—PTGS2—abdominal aortic aneurysm	5.39e-05	9.65e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CCL2—abdominal aortic aneurysm	5.36e-05	9.6e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—NFKB1—abdominal aortic aneurysm	5.35e-05	9.57e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—APOE—abdominal aortic aneurysm	5.31e-05	9.5e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—SERPINE1—abdominal aortic aneurysm	5.27e-05	9.43e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MMP9—abdominal aortic aneurysm	5.22e-05	9.35e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—PTGS2—abdominal aortic aneurysm	5.2e-05	9.3e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	5.19e-05	9.29e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	5.17e-05	9.25e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	5.09e-05	9.1e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—NFKB1—abdominal aortic aneurysm	5.07e-05	9.07e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	5.01e-05	8.96e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—NFKB1—abdominal aortic aneurysm	4.89e-05	8.74e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—AGT—abdominal aortic aneurysm	4.8e-05	8.59e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PTGS2—abdominal aortic aneurysm	4.79e-05	8.57e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—APOE—abdominal aortic aneurysm	4.7e-05	8.41e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CCL2—abdominal aortic aneurysm	4.63e-05	8.29e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—PTGS2—abdominal aortic aneurysm	4.6e-05	8.23e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	4.53e-05	8.11e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCL2—abdominal aortic aneurysm	4.46e-05	7.99e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—NFKB1—abdominal aortic aneurysm	4.33e-05	7.74e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	4.33e-05	7.74e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PTGS2—abdominal aortic aneurysm	4.22e-05	7.55e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	4.17e-05	7.46e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.98e-05	7.12e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	3.96e-05	7.08e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCL2—abdominal aortic aneurysm	3.95e-05	7.07e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.94e-05	7.04e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.9e-05	6.97e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—AGT—abdominal aortic aneurysm	3.88e-05	6.93e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.85e-05	6.9e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.83e-05	6.86e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—APOE—abdominal aortic aneurysm	3.8e-05	6.79e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.79e-05	6.79e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	3.69e-05	6.6e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.31e-05	5.93e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.28e-05	5.87e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MMP9—abdominal aortic aneurysm	3.19e-05	5.71e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NFKB1—abdominal aortic aneurysm	3.16e-05	5.65e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MMP9—abdominal aortic aneurysm	2.83e-05	5.06e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NFKB1—abdominal aortic aneurysm	2.8e-05	5e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PTGS2—abdominal aortic aneurysm	2.6e-05	4.66e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	2.09e-05	3.74e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	2.05e-05	3.67e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	1.4e-05	2.51e-05	CbGpPWpGaD
